Charise Gleason, MSN, NP-C, AOCNP, Kathryn Maples, PharmD, BCOP, and Chelsea Sprouse, FNP-C, provide their perspectives on how to counsel patients on the best frontline treatment options for newly-diagnosed MM, and how this differs from relapsed/refractory MM, where individualizing treatment plans based on the patient needs and tolerability of treatment is key.
Video Library —July 13, 2020
Categories:
Interview with the InnovatorsAdvanced Practice Provider Chief, Winship Cancer Institute,
Emory University,
Atlanta, GA
Emory University,
Atlanta, GA
Nurse Practitioner, Inpatient and Outpatient Malignant Hematology,
Levine Cancer Institute,
Charlotte, NC
Levine Cancer Institute,
Charlotte, NC
Clinical Pharmacy Specialist, Multiple Myeloma, and PGY2 Oncology Residency Research Coordinator,
Winship Cancer Institute, Emory Healthcare,
Atlanta, GA
Winship Cancer Institute, Emory Healthcare,
Atlanta, GA
Last modified: August 10, 2023